Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients

Bradley C. Clark, Justin Georgekutty, Charles I. Berul

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.

Original languageEnglish (US)
Pages (from-to)757-761.e1
JournalJournal of Pediatrics
Volume167
Issue number3
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Myocardial Ischemia
Pediatrics
Cannabinoids
Cardiac Arrhythmias
Myocardial Infarction
cannabinoid K2

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients. / Clark, Bradley C.; Georgekutty, Justin; Berul, Charles I.

In: Journal of Pediatrics, Vol. 167, No. 3, 01.01.2015, p. 757-761.e1.

Research output: Contribution to journalArticle

Clark, Bradley C. ; Georgekutty, Justin ; Berul, Charles I. / Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients. In: Journal of Pediatrics. 2015 ; Vol. 167, No. 3. pp. 757-761.e1.
@article{e50f5b2a3e3c4856b51f8c9030cdd247,
title = "Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients",
abstract = "K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.",
author = "Clark, {Bradley C.} and Justin Georgekutty and Berul, {Charles I.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.jpeds.2015.06.001",
language = "English (US)",
volume = "167",
pages = "757--761.e1",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients

AU - Clark, Bradley C.

AU - Georgekutty, Justin

AU - Berul, Charles I.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.

AB - K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.

UR - http://www.scopus.com/inward/record.url?scp=84940449033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940449033&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2015.06.001

DO - 10.1016/j.jpeds.2015.06.001

M3 - Article

C2 - 26165442

AN - SCOPUS:84940449033

VL - 167

SP - 757-761.e1

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 3

ER -